Clinical Trial Update: Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update examining a nonmyeloablative peripheral blood stem cell transplantation approach for sickle cell disease and beta-thalassemia in patients a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease, Thalassemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-29